To elucidate the pathophysiological role of lysosomal cholesterol accumulation in CLS-constituting macrophages in the development of NASH, MC4R-KO mice received subcutaneous administration of βCD-PRX for 6 wk, after they developed NASH (Fig. 4 A). This evidence concerns the gene MC4R and metabolic dysfunction-associated steatohepatitis.